Elevated level of serum retinol-binding protein 4 in pregnancy-induced hypertension

Journal of Obstetrics and Gynaecology Research

Volumn 35, Issue 2, 2009, Pages 293-300

  Inoue, Seiji ^a   Takamoto, Norio ^a   Akahori, Yoichiro ^a   Masumoto, Akio ^a   Nakatsukasa, Hideki ^a   Msuyama, Hisashi ^a   Hiramatsu, Yuji ^a  

^a OKAYAMA UNIVERSITY   (Japan)

Author keywords

Insulin resistance; Metabolic syndrome; Pregnancy induced hypertension; Retinol binding protein 4

Indexed keywords

RETINOL BINDING PROTEIN 4;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS CIRCULATION; FETUS GROWTH; GESTATION PERIOD; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL BLOOD; MATERNAL HYPERTENSION; PREGNANCY; PROTEIN BLOOD LEVEL; UMBILICAL CORD BLOOD; WESTERN BLOTTING;

ADULT; BODY MASS INDEX; FEMALE; FETAL BLOOD; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY; RETINOL-BINDING PROTEINS, PLASMA;

EID: 63149151582     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2008.00950.x     Document Type: Article

References (31)

1. Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005 436 : 356 362.
2. Graham TE, Yang Q, Bluher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006 354 : 2552 2563.
3. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced insulin resistance in mice lacking TNF-a function. Nature 1997 389 : 610 614.
4. Fernandez-Real JM, Gutierrez C, Ricart W et al. The TNF-alpha gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997 46 : 1468 1472.
5. Kirwan JP, Mouzon SHD, Lepercq J et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002 51 : 2207 2213.
6. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981 30 : 219 225.
7. Reavens GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: The role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996 334 : 374 381.
8. DcFronzo RA, Cooke C, Andres R, Faloona GR, Davis PJ. The effect of insulin in renal handling of sodium, calcium, potassium, and phosphate in man. J Clin Invest 1975 55 : 845 855.
9. Doria A, Fioretto P, Avogaro A et al. Insulin resistance is associated with high sodium-lithium countertransport in essential hypertension. Am J Physiol 1991 261 : E684 E691.
10. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994 330 : 1431 1438.
11. Takagi Y. Nutrition assessment protein. Rinsho Byori 2004 301 306.
12. Kuhl C. Insulin secretion and insulin resistance in pregnancy and GDM: Implications for diagnosis and management. Diabetes 1991 40 : 18 24.
13. Catalano PM, Tyzbir ED, Wolfe RR et al. Carbohydrate metabolism during pregnancy in control subjects and in women with gestational diabetes. Am J Physiol 1993 264 : E60 E67.
14. Solomon CG, Seely EW. Hypertension in pregnancy. A manifestation of the insulin resistance syndrome? Hypertension 2001 37 : 232 239.
15. Erez-Weiss I, Erez O, Shoham-Vardi I, Holcberg G, Mazor M. The association between maternal obesity, glucose intolerance and hypertensive disorders of pregnancy in nondiabetic pregnant women. Hypertens Pregnancy 2005 24 : 125 136.
16. Soprano DR, Blaner WS. Plasma retinol-binding protein. In : Sporn MB, Robert AB, Goodman DS (eds). The Retinoids: Biology, Chemistry and Medicine. New York : Raven Press, 1994 257 282.
17. Gavi S, Stuart LM, Kelly P et al. Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes. J Clin Endocrinol Metab 2007 92 : 1886 1890.
18. Cseh K, Baranyi E, Melczer Z, Kaszas E, Palik E, Winkler G. Plasma adiponectin and pregnancy-induced insulin resistance. Diabetes Care 2004 27 : 274 275.
19. Ferrannini E, Buzzigoli G, Bonadonna R et al. Insulin resistance in essential hypertension. N Engl J Med 1987 317 : 350 357.
20. Abbasi F, McLaughlin T, Lamendola C et al. Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy-woman. Arterioscler Thronb Vasc Biol 1999 19 : 2818 2821.
21. Segal KR, Landt M, Klein S. Relationship between insulin resistance and plasma Leptin concentration in lean and obese man. Diabetes 1996 45 : 988 991.
22. Fernandez-Real JM, Broch M, Ricart W et al. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 1998 47 : 1757 1762.
23. Shaarawy M, Didy HE. Thrombomodulin, plasminogen activator inhibitor Type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia. Int J Gynaecol Obstet 1996 55 : 135 139.
24. McCarthy JF, Misra DN, Roberts JM. Maternal plasma leptin is increased in preeclampsia and positively correlates with fetal cord concentration. Am J Obstet Gynecol 1999 180 : 731 736.
25. Mise H, Sagawa N, Matsumoto T et al. Augmented placental production of leptin in preeclampsia: Possible involvement of placental hypoxia. J Clin Endocrinol Metab 1998 83 : 3225 3229.
26. Kupferminc MJ, Peaceman AM, Wigton TR, Rehnberg KA, Socol ML. Tumor necrosis factor-alpha is elevated in plasma and amniotic fluid of patients with severe preeclampsia. Am J Obstet Gynecol 1994 170 : 1752 1757.
27. Vince GS, Startkey PM, Austgulen R, Kwiatkowski D, Redman CW. Interleukin-6, tumour necrosis factor and soluble tumour factor receptors in women with pre-eclampsia. Br J Obstet Gynaecol 1995 102 : 20 25.
28. Kloting N, Graham TE, Berndt J et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007 6 : 79 87.
29. Kinoshita N, Itoh M. Longitudinal variance of fat mass deposition during pregnancy evaluated by ultrasonography: The ratio of visceral fat to subcutaneous fat in the abdomen. Gynecol Obstet Invest 2006 61 : 115 118.
30. Janke J, Engeli S, Boschmann M et al. Retinol-binding protein 4 in human obesity. Diabetes 2006 55 : 2805 2810.
31. Qi Q, Yu Z, Ye X et al. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 2007 92 : 4827 4834.